Navigation Links
ARIUS recognized for entrepreneurial excellence
Date:4/7/2008

ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com.

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements in this release include, but are not limited to, ARIUS successfully advancing its new product programs as well as licensing opportunities. These statements are only predictions and actual events or results may differ materially. Factors that could cause such actual events or results expressed or implied by such forward-looking statements to differ materially from any future results expressed or implied by such statements include, but are not limited to: early stage of development; technology and product development; dependence on and management of current and future corporate collaborations; future capital needs; uncertainty of additional funding; no assurance of market acceptance; dependence on proprietary technology and uncertainty of patent protection; intense competition; manufacturing and market uncertainties; and government regulation. These and other factors are described in detail in ARIUS' Annual Report, forthcoming news releases and other filings with Canadian securities regulatory authorities available at http://www.sedar.com. Forward-looking statements are based on our current expectations and ARIUS is not obligated to update such information to reflect later events or developments.


'/>"/>
SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
2. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
3. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
4. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
5. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
6. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
7. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
10. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
11. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... CHO cell culture supplement? InVitria has what scientists have been ... supplement that improves the growth and productivity of CHO cells. ... is an animal free, well defined and consistent recombinant CHO ... ... (PRWEB) December 16, 2009 -- Scientists working with CHO cells ...
(Date:12/16/2009)... HSP A has been found to be effectinve in improving ... ... 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the ... previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high quality ... yields. HSP-A has been found to be especially effective in ...
(Date:12/15/2009)... 15 Epeius Biotechnologies Corporation, an emerging ... gained international validation of the cutting-edge science behind ... scientists around the world rediscovered the Cyclin ... of cancer pathogenesis and disease progression, and thus ... at the NIH National Cancer Institute investigating the ...
(Date:12/15/2009)... -- Repligen Corporation (Nasdaq: RGEN ) today ... research funding to support the ongoing development of ... Dystrophy Association (MDA). This grant will support ... GMP manufacture of a drug candidate for human ... only provides important funding for Repligen,s research but ...
Breaking Biology Technology:Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... Orexigen(R) Therapeutics,Inc. (Nasdaq: OREX ), a biopharmaceutical company ... obesity, today announced,that the Company will be presenting at ... the Biotech Industry Thursday, September 4, 2008, 10:00 ... UBS Global Life Sciences Conference Tuesday, September ...
... Mass., Aug. 28 RainDance Technologies, Inc.,a provider ... research, today announced a collaboration with the Scripps,Translational ... as a solution to a key bottleneck in ... support STSI in its exciting effort to discover,inherited ...
... 28 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... final approval from the U.S. Food & Drug ... of Ortho McNeil Janssen,s,Razadyne(R) (galantamine hydrobromide), 4 mg, ... launch its generic Razadyne tablets product immediately., ...
Other Biology Technology:RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 2RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 3RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 4RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 5Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5
(Date:12/16/2009)... 7 IgeaCare Solutions Inc. is pleased ... the healthcare communications company previously operating as IgeaCare ... now move forward under new leadership and funding. ... Rochon to the position of Chief Executive Officer. ... on providing a superior servicing and support model; ...
(Date:12/16/2009)... CSC (NYSE: CSC ... for Laboratory Accreditation awarded the International Organization ... to the company,s Test Lab, which is ... in Fairmont, W.Va. The Test Lab is ... world to achieve this accomplishment. ,, ...
(Date:12/15/2009)... Mo. As soon as babies are born, ... jaundice and e-coli. For up to a month, their ... these infections are often minor, they can lead to ... immune systems, University of Missouri researchers have pinpointed a ... to an immune-strengthening vaccine. , "We,re trying to improve ...
Breaking Biology News(10 mins):IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Researchers work on vaccine to improve immune system in newborns 2Post transplant combo can replace toxic immune suppressing drugs in monkeys 51106 1Post transplant combo can replace toxic immune suppressing drugs in monkeys 51106 2Springer launches SpringerImages 9172 1Springer launches SpringerImages 9172 2LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 1LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 2LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 3LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 4LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 5
... Through studying pigeons with genetic heart disease, researchers at ... clue about why some patients' heart vessels are prone ... identified a regulator of genes that controls the growth ... senior researcher. "Learning to modulate the uncontrolled growth of ...
... A Northwestern University research group has discovered that ... is critical to proper embryo formation. , ... in the advanced online issue of the journal ... unstable embryonic growth factor by injecting aggressive melanoma ...
... Methylphenidate (Ritalin) elevates norepinephrine levels in the brains ... nerve signal transmissions in the sensory pathways to ... a Philadelphia research team has found. , Their ... how a stimulant aids people with attention deficit ...
Other Biology News:Pigeons provide clue to solving common problem in heart patients 2Malignant melanoma cells secrete protein required for embryo formation 2Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions 2Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions 3